20.07.2023 - Press Release Crossject signs new licensing agreement on ZENEO Midazolam epilepsy rescue therapy with AFT Pharmaceuticals for Australia & New Zealand Exclusive licensing, distribution and promotion agreement for ZENEO Midazolam in epileptic . Seite 1
Press Release Crossject signs new licensing agreement on ZENEO® Midazolam epilepsy rescue therapy with AFT Pharmaceuticals for Australia & New Zealand.
18.06.2022 - Press Release Agreement with BARDA on ZENEO Midazolam BARDA places a firm order of $60m to CROSSJECT for initial procurement of ZENEO Midazolam into the U.S. Strategic National Stockpile1 as soon as FDA Authorization is obtainedBARDA also . Seite 1